Cushing Syndrome in Dogs: Symptoms, Diagnosis, Treatment & Prognosis
Complete guide to Cushing syndrome in dogs: symptoms checklist, diagnostic tests, treatment options, costs, prognosis, and breeds at risk.
If your dog is drinking more water than usual, losing hair in symmetrical patches, and developing a pot-bellied appearance, you may be looking at one of the most common endocrine disorders in middle-aged and older dogs. Cushing syndrome (hyperadrenocorticism) occurs when a dog's body produces excessive cortisol — the stress hormone — over a prolonged period. It affects an estimated 1 to 2 out of every 1,000 dogs annually, with pituitary-dependent Cushing's accounting for roughly 80-85% of all cases and adrenal tumors responsible for the remaining 15-20%. A small percentage of cases are iatrogenic, meaning they result from prolonged use of corticosteroid medications like prednisone.
Understanding this condition thoroughly can help you catch it early, navigate the diagnostic process confidently, and manage your dog's quality of life effectively. This guide covers everything from early warning signs to long-term prognosis, with real cost ranges you can use to plan your budget.
What Is Cushing Syndrome in Dogs?
Cushing syndrome — technically called hyperadrenocorticism (HAC) — is a hormonal disorder in which the adrenal glands produce too much cortisol. Cortisol is essential for regulating metabolism, immune response, and stress adaptation, but chronic excess causes widespread metabolic disruption.
The condition falls into three categories:
- Pituitary-Dependent Hyperadrenocorticism (PDH): A benign tumor (adenoma) on the pituitary gland overproduces adrenocorticotropic hormone (ACTH), which signals the adrenal glands to pump out excess cortisol. This accounts for 80-85% of cases.
- Adrenal-Dependent Hyperadrenocorticism (ADH): A tumor on one or both adrenal glands directly produces excess cortisol, independent of pituitary signaling. Roughly 50% of adrenal tumors are malignant (adrenocarcinomas). This represents 15-20% of cases.
- Iatrogenic Cushing Syndrome: Caused by prolonged administration of glucocorticoid medications (prednisone, prednisolone, dexamethasone) for conditions like allergies, autoimmune disease, or arthritis. This is fully reversible with a gradual medication taper under veterinary supervision.
Recognizing the Symptoms: Early Warnings vs. Advanced Signs
Cushing syndrome develops gradually — often over months or even years — which makes early detection challenging. Many owners dismiss the initial signs as normal aging. The symptom checklist below is organized by progression stage to help you identify where your dog may fall.
| Severity | Symptoms | What Owners Typically Notice |
|---|---|---|
| Early Warning Signs | Increased thirst (polydipsia) | Water bowl emptied 2-3x faster than before; dog lingers at faucets, toilets, or puddles |
| Early Warning Signs | Increased urination (polyuria) | More frequent potty breaks; house-trained dog begins having accidents indoors |
| Early Warning Signs | Increased appetite (polyphagia) | Dog seems constantly hungry, begs more aggressively, scavenges, may steal food |
| Early Warning Signs | Mild panting increase | More panting at rest, especially at night or in cool environments |
| Moderate / Progressive | Symmetrical hair loss (alopecia) | Thinning coat on flanks, abdomen, and thighs — typically bilateral and symmetrical; head and legs usually spared |
| Moderate / Progressive | Pot-bellied appearance | Abdomen distends due to fat redistribution, liver enlargement (hepatomegaly), and weakened abdominal muscles |
| Moderate / Progressive | Muscle wasting | Visible thinning of limb muscles, particularly hindquarters; dog appears weaker on stairs or jumping |
| Moderate / Progressive | Thin, fragile skin | Skin tears easily, slow wound healing, visible veins on abdomen |
| Moderate / Progressive | Recurrent skin infections | Frequent bacterial or yeast infections, particularly in skin folds |
| Advanced / Severe | Calcinosis cutis | Hard, gritty calcium deposits under the skin, often on the back, neck, or groin — feels like sandpaper |
| Advanced / Severe | Neurological signs | Disorientation, pacing, circling, seizures — indicates macroadenoma (>10mm pituitary tumor) pressing on brain tissue |
| Advanced / Severe | Thromboembolism | Sudden hind limb weakness or paralysis, acute respiratory distress — caused by blood clots (a life-threatening complication) |
| Advanced / Severe | Diabetes mellitus (comorbidity) | Excessive glucose in blood due to cortisol-induced insulin resistance; occurs in ~10% of untreated Cushing's dogs |
A commonly referenced clinical rule of thumb: if your dog exhibits three or more early-to-moderate symptoms simultaneously, Cushing syndrome should be on the differential diagnosis list and warrants a veterinary endocrine workup.
Risk Factors: Which Dogs Are Most Vulnerable?
- Age: Most commonly diagnosed in dogs aged 7-12 years; median age at diagnosis is approximately 10 years. Rare in dogs under 6.
- Breed predisposition: Poodles (especially Miniature and Standard), Dachshunds, small Terriers (Yorkshire, Boston, Cairn), Beagles, Cocker Spaniels, German Shepherds, and Boxers show higher incidence rates.
- Sex: Female dogs are slightly overrepresented in PDH cases (~60% of pituitary-dependent diagnoses), though the difference is modest.
- Size: PDH is more common in small-to-medium breeds (<44 lb / 20 kg); adrenal tumors show less breed-size specificity but are proportionally more common in larger breeds.
- Medication history: Dogs receiving long-term corticosteroid therapy (oral, injectable, or topical) for chronic allergies, ear infections, or immune-mediated conditions are at elevated risk for iatrogenic Cushing's.
- Genetics: Familial clustering has been observed in some breeds, particularly Poodles and Dachshunds, suggesting a heritable component, though no single causative gene has been identified.
How Is Cushing Syndrome Diagnosed?
Diagnosing Cushing syndrome is a multi-step process because no single test is 100% definitive, and several other conditions (hypothyroidism, diabetes, liver disease) can mimic its symptoms. Your veterinarian will typically follow a staged diagnostic approach.
Step 1: Screening Bloodwork & Urinalysis
A complete blood count (CBC), serum biochemistry panel, and urinalysis form the baseline. Common findings in Cushing's dogs include:
- Elevated alkaline phosphatase (ALP) — often 2-5x normal range
- Elevated ALT (alanine aminotransferase)
- Elevated blood glucose (mild to moderate)
- Elevated cholesterol and triglycerides
- Dilute urine (low urine specific gravity, typically <1.020)
- Stress leukogram: elevated neutrophils, decreased lymphocytes and eosinophils
Estimated cost: $150–$300 for CBC, chemistry panel, and urinalysis combined.
Step 2: Confirmatory Endocrine Testing
If screening bloodwork suggests Cushing syndrome, your vet will order one or both of the following confirmatory tests:
Low-Dose Dexamethasone Suppression Test (LDDST): This is considered the gold-standard screening test. Blood is drawn before and at 4 and 8 hours after a low-dose dexamethasone injection. In a healthy dog, dexamethasone suppresses cortisol production; in a Cushing's dog, cortisol remains elevated. Sensitivity is approximately 85-95% for PDH and ~95%+ for ADH.
ACTH Stimulation Test: Blood is drawn before and 1 hour after synthetic ACTH (cosyntropin) injection. Measures the adrenal glands' maximum cortisol output. Sensitivity is ~80-85% for PDH but lower (~60%) for ADH. This test is also essential for monitoring treatment response once therapy begins.
Estimated cost: $200–$400 per confirmatory test. Some clinics run both, adding $400–$700 to the diagnostic bill.
Step 3: Differentiating PDH from ADH
Once Cushing syndrome is confirmed, determining whether it's pituitary- or adrenal-dependent is critical because treatment strategies differ significantly:
High-Dose Dexamethasone Suppression Test (HDDST): A higher dose of dexamethasone is administered. In ~65% of PDH cases, cortisol suppresses at the higher dose; adrenal tumors do not suppress regardless of dose.
Endogenous ACTH Concentration: A single blood draw measuring the dog's natural ACTH level. High ACTH suggests PDH (pituitary is over-signaling); low ACTH suggests ADH (adrenal tumor is producing cortisol independently, suppressing pituitary output).
Abdominal Ultrasound: Evaluates adrenal gland size and shape. Bilateral enlargement suggests PDH; a single enlarged gland with contralateral atrophy suggests ADH. Also assesses liver size and checks for metastatic disease. Cost: $300–$600.
CT or MRI (Advanced Imaging): Reserved for cases where neurological signs suggest a pituitary macroadenoma or when surgical planning for an adrenal tumor is needed. Cost: $1,200–$3,000+.
Treatment Options: Medical, Surgical, and Supportive
Cushing syndrome treatment depends on the type (PDH vs. ADH), severity, and whether the dog has comorbidities like diabetes or neurological signs. Here is a detailed comparison of available options.
| Treatment | Type Treated | Mechanism | Success Rate / Efficacy | Monthly Cost | Key Considerations |
|---|---|---|---|---|---|
| Trilostane (Vetoryl) | PDH and ADH | Inhibits 3β-hydroxysteroid dehydrogenase, blocking cortisol synthesis in the adrenal glands | ~80-85% clinical improvement within 2-4 weeks; considered first-line treatment | $50–$200/month depending on dose and dog size | Requires lifelong daily administration; ACTH stim monitoring every 3-6 months initially; rare but serious side effect: adrenal necrosis |
| Mitotane (Lysodren) | PDH primarily | Selectively destroys the zona fasciculata and zona reticularis of the adrenal cortex | ~70-85% response rate; faster onset than trilostane in some cases | $30–$100/month | Requires careful "loading phase" with daily monitoring; higher risk of Addisonian crisis if over-dosed; less commonly used as first-line since trilostane's FDA approval |
| Adrenalectomy (surgical removal) | ADH (adrenal tumors) | Removes the cortisol-producing adrenal tumor entirely | Curative in benign adenomas; 1-3 year survival for malignant adrenocarcinomas with surgery alone; combined with mitotane, survival may extend | $3,000–$8,000 (one-time surgical cost) | High-risk surgery requiring board-certified surgeon; ~10-20% perioperative complication rate; may require temporary post-operative cortisol supplementation |
| Hypophysectomy (pituitary surgery) | PDH | Removes the pituitary tumor directly | ~70-80% remission rate at 1 year; 2-4 year median survival post-surgery reported in specialized centers | $5,000–$12,000 (one-time surgical cost) | Only available at a handful of veterinary teaching hospitals and specialty centers worldwide; requires lifelong thyroid and cortisol supplementation post-surgery |
| Radiation therapy | PDH (macroadenomas) | Targets pituitary macroadenomas to shrink tumor and reduce neurological signs | Improves neurological signs in ~70-75% of cases; does not normalize cortisol levels alone — usually combined with trilostane | $4,000–$8,000 (total course) | Requires multiple sessions under general anesthesia; may take 3-6 months to see full response; limited availability |
| Supportive / Palliative Care | Any type where treatment is declined or contraindicated | Manages symptoms without targeting the underlying cause | Variable; does not halt disease progression | $20–$80/month | Includes managing secondary infections, dietary adjustments, skin care; may provide months of acceptable quality of life in mild cases |
Trilostane (Vetoryl): The Standard of Care
Since receiving FDA approval in 2008, trilostane has become the most widely prescribed medication for canine Cushing syndrome. It is administered once or twice daily with food (twice-daily dosing has shown better cortisol control in some studies). The starting dose is typically 1-2 mg/kg once daily, adjusted based on ACTH stimulation test results at 10-14 days, 30 days, 90 days, and then every 3-6 months.
Important safety note: Never adjust trilostane dosage without veterinary guidance. Over-suppression of cortisol can trigger an Addisonian crisis (hypoadrenocorticism), which is a medical emergency characterized by vomiting, diarrhea, collapse, and electrolyte imbalances.
Managing Iatrogenic Cushing Syndrome
If your dog's Cushing symptoms are caused by prolonged corticosteroid use, treatment involves a carefully supervised, gradual tapering of the offending medication. This process typically takes weeks to months — abrupt discontinuation of steroids can cause a life-threatening Addisonian crisis. Your veterinarian will design a tapering schedule specific to your dog's dose, duration of use, and underlying condition being treated.
Prognosis and Life Expectancy
Prognosis varies considerably based on the type, stage at diagnosis, and treatment approach. Here's a realistic breakdown:
| Category | Median Survival Time | Quality of Life Outlook |
|---|---|---|
| PDH — medically managed (trilostane) | 2–2.5 years (range: 6 months to 5+ years with good monitoring) | Generally good once stabilized; most dogs return to near-normal activity levels within 4-8 weeks |
| PDH — untreated | 6–12 months on average; progressive deterioration | Poor; escalating symptoms, high risk of secondary complications (infections, diabetes, thromboembolism) |
| PDH — pituitary macroadenoma | 6–18 months depending on tumor size and neurological involvement | Guarded; neurological signs may progress despite medical management; radiation may improve outcomes |
| ADH — benign adenoma, surgically removed | Curative in many cases; normal life expectancy post-recovery | Excellent once recovered from surgery (1-3 month recovery period) |
| ADH — malignant adrenocarcinoma | 12–18 months with surgery; shorter if metastasis present | Guarded to fair; depends on metastatic spread at diagnosis; adjuvant mitotane may extend survival |
| Iatrogenic Cushing syndrome | Full recovery expected if steroid taper is managed correctly | Excellent; symptoms resolve gradually over weeks to months after medication adjustment |
According to a study published in the Journal of Veterinary Internal Medicine, dogs with PDH treated with trilostane had a median survival of approximately 662 days (~22 months), with many dogs living 3-4 years with consistent monitoring and dose adjustments.
Home Care, Monitoring, and Daily Management
Living with a Cushing's dog requires a structured routine. Here's what daily and long-term management looks like:
Daily Care
- Medication administration: Give trilostane or mitotane at the same time(s) every day, always with food to improve absorption and reduce GI upset.
- Water access: Never restrict water intake. Your dog's increased thirst is a physiological response — limiting water can lead to dangerous dehydration. Keep multiple water stations available.
- Frequent potty breaks: Expect 4-6 outdoor bathroom breaks per day during the initial treatment phase. As cortisol levels normalize, urination frequency typically decreases.
- Appetite management: Increased appetite may persist for weeks after starting treatment. Feed measured portions of a balanced, AAFCO-approved diet rather than free-feeding to prevent obesity.
- Skin and coat monitoring: Check for new infections, hot spots, or changes in calcinosis cutis lesions weekly. Hair regrowth typically begins 3-6 months after successful treatment initiation.
Veterinary Monitoring Schedule
- 10-14 days post-diagnosis: First ACTH stimulation test to assess initial trilostane response and adjust dose
- 30 days: Second ACTH stim + chemistry panel
- 90 days: Third ACTH stim + full bloodwork
- Every 3-6 months thereafter: Ongoing ACTH stim monitoring, dose adjustments as needed, blood pressure checks
- Annual: Abdominal ultrasound to monitor adrenal gland size (PDH) or check for recurrence (post-adrenalectomy)
Dietary Considerations
Dogs with Cushing syndrome benefit from a diet that is:
- Moderate in high-quality protein (to support muscle maintenance without overloading the kidneys)
- Low in fat (Cushing's dogs are prone to hyperlipidemia and pancreatitis)
- Moderate in fiber (helps manage appetite and blood glucose)
- Low in sodium (especially if hypertension is present)
Consult your veterinarian before making dietary changes. If your dog also has Cushing-related diabetes, a veterinary nutritionist can formulate a tailored plan.
Cost Breakdown: What to Budget
Cushing syndrome is a chronic condition requiring ongoing financial commitment. Here's a realistic cost breakdown for 2026:
| Expense Category | Cost Range | Frequency |
|---|---|---|
| Initial diagnostic workup (bloodwork + confirmatory tests + ultrasound) | $800–$2,500 | One-time |
| Advanced imaging (CT/MRI) if needed | $1,500–$3,500 | One-time |
| Trilostane (Vetoryl) medication | $50–$200/month | Ongoing (lifelong) |
| ACTH stimulation monitoring tests | $150–$350 per test | 4-6 times in year one; 2-3 times annually thereafter |
| Routine bloodwork and urinalysis | $150–$300 | Every 3-6 months |
| Adrenalectomy (if ADH) | $3,000–$8,000 | One-time |
| Hypophysectomy (if available, PDH) | $5,000–$12,000 | One-time |
| Radiation therapy (macroadenoma) | $4,000–$8,000 | One-time course |
| Estimated First-Year Total (PDH, medical management) | $2,500–$6,000 | — |
| Estimated Annual Ongoing Cost (Years 2+) | $1,200–$3,500 | — |
Pet insurance consideration: If your dog was enrolled in a comprehensive pet insurance policy before diagnosis, most plans cover Cushing syndrome diagnostics and treatment. Policies typically reimburse 70-90% after deductible. However, if Cushing's is diagnosed before enrollment, it will be classified as a pre-existing condition and excluded. This underscores the value of enrolling puppies in insurance early.
When to See the Vet Immediately
- Sudden collapse, extreme lethargy, or inability to stand — may indicate Addisonian crisis (especially if your dog is on trilostane or mitotane) or thromboembolism
- Acute vomiting and diarrhea that doesn't resolve within 12 hours — potential adrenal crisis or pancreatitis
- Seizures, disorientation, head pressing, or circling — may indicate pituitary macroadenoma expansion or stroke
- Sudden hind limb weakness or paralysis — possible pulmonary thromboembolism (blood clot), a known complication of Cushing syndrome
- Rapid, labored breathing or open-mouth breathing at rest — may signal pulmonary thromboembolism or congestive heart failure
- Complete refusal to eat or drink for more than 24 hours — especially concerning in a dog previously exhibiting polyphagia
If your dog is currently being treated with trilostane or mitotane and shows any of these signs, contact your veterinarian immediately. Do NOT administer the next dose of medication until instructed by your vet. An Addisonian crisis requires emergency IV fluid therapy and glucocorticoid administration.
Can Cushing Syndrome Be Prevented?
Unfortunately, naturally occurring Cushing syndrome (both PDH and ADH) cannot be prevented — it arises from spontaneous tumors with no known modifiable risk factors. However, there are practical steps you can take:
- Minimize unnecessary corticosteroid use: Work with your veterinarian to explore steroid-sparing alternatives for chronic conditions (allergies, ear infections). Options include oclacitinib (Apoquel), lokivetmab (Cytopoint), topical therapies, and allergen-specific immunotherapy.
- Early detection through senior wellness exams: Annual or biannual bloodwork for dogs over 7 years old can catch elevated ALP and other early markers before clinical symptoms become severe.
- Monitor high-risk breeds: If you own a Poodle, Dachshund, or small Terrier breed, be especially vigilant about the "big three" early symptoms: increased thirst, increased urination, and increased appetite.
- Track medication history: Keep detailed records of all corticosteroid prescriptions (drug name, dose, duration) so your veterinarian can assess iatrogenic risk.
Frequently Asked Questions
Is Cushing syndrome in dogs fatal?
Untreated Cushing syndrome is progressive and ultimately life-threatening due to complications like diabetes, infections, thromboembolism, and organ damage. However, with appropriate treatment and consistent monitoring, most dogs live 2-3 years or more with good quality of life. Some dogs with well-managed PDH live 4-5+ years after diagnosis.
Can I treat my dog's Cushing syndrome naturally or without medication?
There is no scientifically validated natural or alternative treatment that effectively controls cortisol overproduction in canine Cushing syndrome. Supplements marketed for "adrenal support" (melatonin, lignans from flaxseed, ashwagandha) have not demonstrated clinically significant cortisol reduction in peer-reviewed studies. Some owners use melatonin or flaxseed lignans as complementary support alongside prescribed medication — discuss this with your veterinarian before adding any supplements, as interactions are possible.
What's the difference between Cushing syndrome and Addison's disease?
They are opposites. Cushing syndrome (hyperadrenocorticism) involves excess cortisol production. Addison's disease (hypoadrenocorticism) involves insufficient cortisol and aldosterone production. Paradoxically, over-treatment of Cushing syndrome with trilostane or mitotane can induce iatrogenic Addison's disease, which is why careful dose titration and monitoring are essential.
Will my dog's hair grow back after Cushing's treatment?
In most cases, yes — but it takes time. Hair regrowth typically begins 3-6 months after cortisol levels are stabilized, with full coat recovery potentially taking 6-12 months. Some dogs with long-standing Cushing's may have permanent thinning in certain areas, particularly if calcinosis cutis has damaged hair follicles.
Should I see a veterinary specialist for Cushing syndrome?
Many general practice veterinarians manage straightforward PDH cases effectively with trilostane. However, referral to a board-certified veterinary internal medicine specialist (DACVIM) is recommended if: your dog's case is not responding to standard treatment, neurological signs are present, an adrenal tumor is suspected (surgical candidate), or if you want a second opinion on the diagnosis. The American College of Veterinary Internal Medicine maintains a directory of certified specialists.
How do I know if my dog's Cushing treatment is working?
Improvement is typically seen in this order: decreased thirst and urination (within 1-4 weeks), reduced appetite (2-6 weeks), improved energy and activity level (4-8 weeks), and coat regrowth (3-6+ months). Your veterinarian will confirm biochemical control through ACTH stimulation testing — clinical improvement alone is not sufficient to confirm adequate cortisol suppression.
Disclaimer: This article is for informational purposes only and does not replace professional veterinary advice. Always consult your veterinarian for diagnosis, treatment planning, and medication management for your dog. If you suspect your dog has Cushing syndrome, schedule a veterinary appointment promptly — early diagnosis improves treatment outcomes and quality of life.
Beth Carrasco
All our authors care for dogs every day — read more of their work on the authors page.



